Global Perphenazine Drug Market Growth 2026-2032
The global Perphenazine Drug market size is predicted to grow from US$ 105 million in 2025 to US$ 133 million in 2032; it is expected to grow at a CAGR of 3.4% from 2026 to 2032.
Perphenazine drug is a typical antipsychotic belonging to the phenothiazine class of dopamine receptor antagonists. It mainly acts by blocking dopamine D2 receptors in the central nervous system to improve symptoms associated with schizophrenia and other psychotic disorders, such as hallucinations, delusions, excitement, agitation, and disorganized thinking, and in some markets it is also used to control severe nausea, vomiting, or hiccups. Perphenazine is commonly supplied as oral tablets, with clinical positioning centered on established efficacy, affordability, long-term accumulated use experience, and stable access in primary care settings. Compared with newer atypical antipsychotics, perphenazine is not a high-premium innovative drug, but a mature medicine with fundamental treatment value in psychiatric specialties, psychiatric departments of general hospitals, and primary chronic disease management. Its commercial value is increasingly reflected in standardized prescribing, stable supply, quality consistency, pharmacovigilance, and coverage within mental health service systems.In 2025, global Perphenazine Drug production reached approximately 15.6 million units.The average gross profit margin of this product is 35%.
The core opportunities in the perphenazine drug market come from the improvement of mental health service systems, the promotion of standardized management for severe mental disorders, enhanced medication accessibility in primary healthcare institutions, and the fundamental value of mature antipsychotics in long-term maintenance therapy. Continued government emphasis on mental health prevention, community management, and essential drug supply gives classic medicines with established efficacy, controllable cost, and stable availability both public health value and clinical fallback importance. For companies, perphenazine is not a product driven by high-price innovation narratives, but by stable quality, channel coverage, primary care distribution, hospital access, and long-term prescribing trust. Against the backdrop of uneven psychiatric resource distribution and the need to support long-term patient adherence, mature antipsychotics remain an essential category within the mental health system.
The main challenges in the perphenazine industry are high product maturity, sufficient generic competition, and limited price elasticity, making it difficult for companies to obtain high premiums through marketing alone. As a first-generation antipsychotic, perphenazine requires clinical attention to safety issues such as extrapyramidal symptoms, tardive dyskinesia, sedation, hypotension, anticholinergic reactions, drug interactions, and medication risks in elderly patients, meaning market promotion must be based on standardized prescribing and risk management. With increasing use of atypical antipsychotics and long-acting injectables in certain patient groups, perphenazine is more often positioned for cost-sensitive patients, those with stable efficacy, those with good prior response, or populations requiring basic treatment coverage. Companies lacking consistency evaluation, stable production, pharmacovigilance, and clinical education capabilities may lose competitiveness in centralized procurement, hospital substitution, and quality supervision.
Downstream demand is shifting from simple drug procurement toward stable supply and standardized medication use built around long-term psychiatric disease management. Psychiatric hospitals, psychiatric departments of general hospitals, primary chronic disease management institutions, community mental health service networks, and reimbursement systems are important pillars supporting sustained demand for perphenazine. Clinicians increasingly focus on predictable efficacy, convenience of dose adjustment, adverse reaction monitoring, safety in combination with other psychiatric medicines, and long-term medication accessibility; patients and families place greater emphasis on drug affordability, uninterrupted supply, and stable symptom control. In the future, perphenazine products with consistent quality, stable pricing, broad channel penetration, robust pharmacovigilance, and physician trust will be better positioned to maintain market vitality in primary mental health care, long-term maintenance therapy, and public health-oriented medication supply.
LP Information, Inc. (LPI) ' newest research report, the ?Perphenazine Drug Industry Forecast? looks at past sales and reviews total world Perphenazine Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Perphenazine Drug sales for 2026 through 2032. With Perphenazine Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Perphenazine Drug industry.
This Insight Report provides a comprehensive analysis of the global Perphenazine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Perphenazine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Perphenazine Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Perphenazine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Perphenazine Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Perphenazine Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Perphenazine Drug market?
What factors are driving Perphenazine Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Perphenazine Drug market opportunities vary by end market size?
How does Perphenazine Drug break out by Type, by Application?
Perphenazine drug is a typical antipsychotic belonging to the phenothiazine class of dopamine receptor antagonists. It mainly acts by blocking dopamine D2 receptors in the central nervous system to improve symptoms associated with schizophrenia and other psychotic disorders, such as hallucinations, delusions, excitement, agitation, and disorganized thinking, and in some markets it is also used to control severe nausea, vomiting, or hiccups. Perphenazine is commonly supplied as oral tablets, with clinical positioning centered on established efficacy, affordability, long-term accumulated use experience, and stable access in primary care settings. Compared with newer atypical antipsychotics, perphenazine is not a high-premium innovative drug, but a mature medicine with fundamental treatment value in psychiatric specialties, psychiatric departments of general hospitals, and primary chronic disease management. Its commercial value is increasingly reflected in standardized prescribing, stable supply, quality consistency, pharmacovigilance, and coverage within mental health service systems.In 2025, global Perphenazine Drug production reached approximately 15.6 million units.The average gross profit margin of this product is 35%.
The core opportunities in the perphenazine drug market come from the improvement of mental health service systems, the promotion of standardized management for severe mental disorders, enhanced medication accessibility in primary healthcare institutions, and the fundamental value of mature antipsychotics in long-term maintenance therapy. Continued government emphasis on mental health prevention, community management, and essential drug supply gives classic medicines with established efficacy, controllable cost, and stable availability both public health value and clinical fallback importance. For companies, perphenazine is not a product driven by high-price innovation narratives, but by stable quality, channel coverage, primary care distribution, hospital access, and long-term prescribing trust. Against the backdrop of uneven psychiatric resource distribution and the need to support long-term patient adherence, mature antipsychotics remain an essential category within the mental health system.
The main challenges in the perphenazine industry are high product maturity, sufficient generic competition, and limited price elasticity, making it difficult for companies to obtain high premiums through marketing alone. As a first-generation antipsychotic, perphenazine requires clinical attention to safety issues such as extrapyramidal symptoms, tardive dyskinesia, sedation, hypotension, anticholinergic reactions, drug interactions, and medication risks in elderly patients, meaning market promotion must be based on standardized prescribing and risk management. With increasing use of atypical antipsychotics and long-acting injectables in certain patient groups, perphenazine is more often positioned for cost-sensitive patients, those with stable efficacy, those with good prior response, or populations requiring basic treatment coverage. Companies lacking consistency evaluation, stable production, pharmacovigilance, and clinical education capabilities may lose competitiveness in centralized procurement, hospital substitution, and quality supervision.
Downstream demand is shifting from simple drug procurement toward stable supply and standardized medication use built around long-term psychiatric disease management. Psychiatric hospitals, psychiatric departments of general hospitals, primary chronic disease management institutions, community mental health service networks, and reimbursement systems are important pillars supporting sustained demand for perphenazine. Clinicians increasingly focus on predictable efficacy, convenience of dose adjustment, adverse reaction monitoring, safety in combination with other psychiatric medicines, and long-term medication accessibility; patients and families place greater emphasis on drug affordability, uninterrupted supply, and stable symptom control. In the future, perphenazine products with consistent quality, stable pricing, broad channel penetration, robust pharmacovigilance, and physician trust will be better positioned to maintain market vitality in primary mental health care, long-term maintenance therapy, and public health-oriented medication supply.
LP Information, Inc. (LPI) ' newest research report, the ?Perphenazine Drug Industry Forecast? looks at past sales and reviews total world Perphenazine Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Perphenazine Drug sales for 2026 through 2032. With Perphenazine Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Perphenazine Drug industry.
This Insight Report provides a comprehensive analysis of the global Perphenazine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Perphenazine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Perphenazine Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Perphenazine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Perphenazine Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Perphenazine Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral Forms
- Injectable Solution
- Schizophrenia
- Severe Nausea and Vomiting
- Other
- Psychiatric Hospital
- General Hospital Psychiatry
- Retail Pharmacy
- Psychosis
- Antiemetic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva Pharmaceutical
- Sandoz
- Hikma Pharmaceuticals
- Amneal Pharmaceuticals
- Shanghai Sine Pharmaceutical
- Hunan Dongting Pharmaceutical
- Shanghai Zhaohui Pharmaceutical
- Endo International
- Mitsubishi Tanabe
What is the 10-year outlook for the global Perphenazine Drug market?
What factors are driving Perphenazine Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Perphenazine Drug market opportunities vary by end market size?
How does Perphenazine Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Perphenazine Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Perphenazine Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Perphenazine Drug by Country/Region, 2021, 2025 & 2032
2.2 Perphenazine Drug Segment by Type
2.2.1 Oral Forms
2.2.2 Injectable Solution
2.2.3 Perphenazine Drug Sales by Type
2.2.3.1 Global Perphenazine Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global Perphenazine Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Perphenazine Drug Sale Price by Type (2021-2026)
2.3 Perphenazine Drug Segment by Psychiatric Indication
2.3.1 Schizophrenia
2.3.2 Severe Nausea and Vomiting
2.3.3 Other
2.3.4 Perphenazine Drug Sales by Psychiatric Indication
2.3.4.1 Global Perphenazine Drug Sales Market Share by Psychiatric Indication (2021-2026)
2.3.4.2 Global Perphenazine Drug Revenue and Market Share by Psychiatric Indication (2021-2026)
2.3.4.3 Global Perphenazine Drug Sale Price by Psychiatric Indication (2021-2026)
2.4 Perphenazine Drug Segment by Generic Supply Type
2.4.1 Psychiatric Hospital
2.4.2 General Hospital Psychiatry
2.4.3 Retail Pharmacy
2.4.4 Perphenazine Drug Sales by Generic Supply Type
2.4.4.1 Global Perphenazine Drug Sales Market Share by Generic Supply Type (2021-2026)
2.4.4.2 Global Perphenazine Drug Revenue and Market Share by Generic Supply Type (2021-2026)
2.4.4.3 Global Perphenazine Drug Sale Price by Generic Supply Type (2021-2026)
2.5 Perphenazine Drug Segment by Application
2.5.1 Psychosis
2.5.2 Antiemetic
2.5.3 Perphenazine Drug Sales by Application
2.5.3.1 Global Perphenazine Drug Sale Market Share by Application (2021-2026)
2.5.3.2 Global Perphenazine Drug Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Perphenazine Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Perphenazine Drug Breakdown Data by Company
3.1.1 Global Perphenazine Drug Annual Sales by Company (2021-2026)
3.1.2 Global Perphenazine Drug Sales Market Share by Company (2021-2026)
3.2 Global Perphenazine Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Perphenazine Drug Revenue by Company (2021-2026)
3.2.2 Global Perphenazine Drug Revenue Market Share by Company (2021-2026)
3.3 Global Perphenazine Drug Sale Price by Company
3.4 Key Manufacturers Perphenazine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Perphenazine Drug Product Location Distribution
3.4.2 Players Perphenazine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERPHENAZINE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Perphenazine Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Perphenazine Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Perphenazine Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Perphenazine Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Perphenazine Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Perphenazine Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Perphenazine Drug Sales Growth
4.4 APAC Perphenazine Drug Sales Growth
4.5 Europe Perphenazine Drug Sales Growth
4.6 Middle East & Africa Perphenazine Drug Sales Growth
5 AMERICAS
5.1 Americas Perphenazine Drug Sales by Country
5.1.1 Americas Perphenazine Drug Sales by Country (2021-2026)
5.1.2 Americas Perphenazine Drug Revenue by Country (2021-2026)
5.2 Americas Perphenazine Drug Sales by Type (2021-2026)
5.3 Americas Perphenazine Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Perphenazine Drug Sales by Region
6.1.1 APAC Perphenazine Drug Sales by Region (2021-2026)
6.1.2 APAC Perphenazine Drug Revenue by Region (2021-2026)
6.2 APAC Perphenazine Drug Sales by Type (2021-2026)
6.3 APAC Perphenazine Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Perphenazine Drug by Country
7.1.1 Europe Perphenazine Drug Sales by Country (2021-2026)
7.1.2 Europe Perphenazine Drug Revenue by Country (2021-2026)
7.2 Europe Perphenazine Drug Sales by Type (2021-2026)
7.3 Europe Perphenazine Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Perphenazine Drug by Country
8.1.1 Middle East & Africa Perphenazine Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Perphenazine Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Perphenazine Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Perphenazine Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Perphenazine Drug
10.3 Manufacturing Process Analysis of Perphenazine Drug
10.4 Industry Chain Structure of Perphenazine Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Perphenazine Drug Distributors
11.3 Perphenazine Drug Customer
12 WORLD FORECAST REVIEW FOR PERPHENAZINE DRUG BY GEOGRAPHIC REGION
12.1 Global Perphenazine Drug Market Size Forecast by Region
12.1.1 Global Perphenazine Drug Forecast by Region (2027-2032)
12.1.2 Global Perphenazine Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Perphenazine Drug Forecast by Type (2027-2032)
12.7 Global Perphenazine Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Information
13.1.2 Teva Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
13.1.3 Teva Pharmaceutical Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Teva Pharmaceutical Main Business Overview
13.1.5 Teva Pharmaceutical Latest Developments
13.2 Sandoz
13.2.1 Sandoz Company Information
13.2.2 Sandoz Perphenazine Drug Product Portfolios and Specifications
13.2.3 Sandoz Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sandoz Main Business Overview
13.2.5 Sandoz Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Perphenazine Drug Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Amneal Pharmaceuticals
13.4.1 Amneal Pharmaceuticals Company Information
13.4.2 Amneal Pharmaceuticals Perphenazine Drug Product Portfolios and Specifications
13.4.3 Amneal Pharmaceuticals Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Amneal Pharmaceuticals Main Business Overview
13.4.5 Amneal Pharmaceuticals Latest Developments
13.5 Shanghai Sine Pharmaceutical
13.5.1 Shanghai Sine Pharmaceutical Company Information
13.5.2 Shanghai Sine Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
13.5.3 Shanghai Sine Pharmaceutical Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Shanghai Sine Pharmaceutical Main Business Overview
13.5.5 Shanghai Sine Pharmaceutical Latest Developments
13.6 Hunan Dongting Pharmaceutical
13.6.1 Hunan Dongting Pharmaceutical Company Information
13.6.2 Hunan Dongting Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
13.6.3 Hunan Dongting Pharmaceutical Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hunan Dongting Pharmaceutical Main Business Overview
13.6.5 Hunan Dongting Pharmaceutical Latest Developments
13.7 Shanghai Zhaohui Pharmaceutical
13.7.1 Shanghai Zhaohui Pharmaceutical Company Information
13.7.2 Shanghai Zhaohui Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
13.7.3 Shanghai Zhaohui Pharmaceutical Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Zhaohui Pharmaceutical Main Business Overview
13.7.5 Shanghai Zhaohui Pharmaceutical Latest Developments
13.8 Endo International
13.8.1 Endo International Company Information
13.8.2 Endo International Perphenazine Drug Product Portfolios and Specifications
13.8.3 Endo International Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Endo International Main Business Overview
13.8.5 Endo International Latest Developments
13.9 Mitsubishi Tanabe
13.9.1 Mitsubishi Tanabe Company Information
13.9.2 Mitsubishi Tanabe Perphenazine Drug Product Portfolios and Specifications
13.9.3 Mitsubishi Tanabe Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mitsubishi Tanabe Main Business Overview
13.9.5 Mitsubishi Tanabe Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Perphenazine Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Perphenazine Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Perphenazine Drug by Country/Region, 2021, 2025 & 2032
2.2 Perphenazine Drug Segment by Type
2.2.1 Oral Forms
2.2.2 Injectable Solution
2.2.3 Perphenazine Drug Sales by Type
2.2.3.1 Global Perphenazine Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global Perphenazine Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Perphenazine Drug Sale Price by Type (2021-2026)
2.3 Perphenazine Drug Segment by Psychiatric Indication
2.3.1 Schizophrenia
2.3.2 Severe Nausea and Vomiting
2.3.3 Other
2.3.4 Perphenazine Drug Sales by Psychiatric Indication
2.3.4.1 Global Perphenazine Drug Sales Market Share by Psychiatric Indication (2021-2026)
2.3.4.2 Global Perphenazine Drug Revenue and Market Share by Psychiatric Indication (2021-2026)
2.3.4.3 Global Perphenazine Drug Sale Price by Psychiatric Indication (2021-2026)
2.4 Perphenazine Drug Segment by Generic Supply Type
2.4.1 Psychiatric Hospital
2.4.2 General Hospital Psychiatry
2.4.3 Retail Pharmacy
2.4.4 Perphenazine Drug Sales by Generic Supply Type
2.4.4.1 Global Perphenazine Drug Sales Market Share by Generic Supply Type (2021-2026)
2.4.4.2 Global Perphenazine Drug Revenue and Market Share by Generic Supply Type (2021-2026)
2.4.4.3 Global Perphenazine Drug Sale Price by Generic Supply Type (2021-2026)
2.5 Perphenazine Drug Segment by Application
2.5.1 Psychosis
2.5.2 Antiemetic
2.5.3 Perphenazine Drug Sales by Application
2.5.3.1 Global Perphenazine Drug Sale Market Share by Application (2021-2026)
2.5.3.2 Global Perphenazine Drug Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Perphenazine Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Perphenazine Drug Breakdown Data by Company
3.1.1 Global Perphenazine Drug Annual Sales by Company (2021-2026)
3.1.2 Global Perphenazine Drug Sales Market Share by Company (2021-2026)
3.2 Global Perphenazine Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Perphenazine Drug Revenue by Company (2021-2026)
3.2.2 Global Perphenazine Drug Revenue Market Share by Company (2021-2026)
3.3 Global Perphenazine Drug Sale Price by Company
3.4 Key Manufacturers Perphenazine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Perphenazine Drug Product Location Distribution
3.4.2 Players Perphenazine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERPHENAZINE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Perphenazine Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Perphenazine Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Perphenazine Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Perphenazine Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Perphenazine Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Perphenazine Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Perphenazine Drug Sales Growth
4.4 APAC Perphenazine Drug Sales Growth
4.5 Europe Perphenazine Drug Sales Growth
4.6 Middle East & Africa Perphenazine Drug Sales Growth
5 AMERICAS
5.1 Americas Perphenazine Drug Sales by Country
5.1.1 Americas Perphenazine Drug Sales by Country (2021-2026)
5.1.2 Americas Perphenazine Drug Revenue by Country (2021-2026)
5.2 Americas Perphenazine Drug Sales by Type (2021-2026)
5.3 Americas Perphenazine Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Perphenazine Drug Sales by Region
6.1.1 APAC Perphenazine Drug Sales by Region (2021-2026)
6.1.2 APAC Perphenazine Drug Revenue by Region (2021-2026)
6.2 APAC Perphenazine Drug Sales by Type (2021-2026)
6.3 APAC Perphenazine Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Perphenazine Drug by Country
7.1.1 Europe Perphenazine Drug Sales by Country (2021-2026)
7.1.2 Europe Perphenazine Drug Revenue by Country (2021-2026)
7.2 Europe Perphenazine Drug Sales by Type (2021-2026)
7.3 Europe Perphenazine Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Perphenazine Drug by Country
8.1.1 Middle East & Africa Perphenazine Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Perphenazine Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Perphenazine Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Perphenazine Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Perphenazine Drug
10.3 Manufacturing Process Analysis of Perphenazine Drug
10.4 Industry Chain Structure of Perphenazine Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Perphenazine Drug Distributors
11.3 Perphenazine Drug Customer
12 WORLD FORECAST REVIEW FOR PERPHENAZINE DRUG BY GEOGRAPHIC REGION
12.1 Global Perphenazine Drug Market Size Forecast by Region
12.1.1 Global Perphenazine Drug Forecast by Region (2027-2032)
12.1.2 Global Perphenazine Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Perphenazine Drug Forecast by Type (2027-2032)
12.7 Global Perphenazine Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Information
13.1.2 Teva Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
13.1.3 Teva Pharmaceutical Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Teva Pharmaceutical Main Business Overview
13.1.5 Teva Pharmaceutical Latest Developments
13.2 Sandoz
13.2.1 Sandoz Company Information
13.2.2 Sandoz Perphenazine Drug Product Portfolios and Specifications
13.2.3 Sandoz Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sandoz Main Business Overview
13.2.5 Sandoz Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Perphenazine Drug Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Amneal Pharmaceuticals
13.4.1 Amneal Pharmaceuticals Company Information
13.4.2 Amneal Pharmaceuticals Perphenazine Drug Product Portfolios and Specifications
13.4.3 Amneal Pharmaceuticals Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Amneal Pharmaceuticals Main Business Overview
13.4.5 Amneal Pharmaceuticals Latest Developments
13.5 Shanghai Sine Pharmaceutical
13.5.1 Shanghai Sine Pharmaceutical Company Information
13.5.2 Shanghai Sine Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
13.5.3 Shanghai Sine Pharmaceutical Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Shanghai Sine Pharmaceutical Main Business Overview
13.5.5 Shanghai Sine Pharmaceutical Latest Developments
13.6 Hunan Dongting Pharmaceutical
13.6.1 Hunan Dongting Pharmaceutical Company Information
13.6.2 Hunan Dongting Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
13.6.3 Hunan Dongting Pharmaceutical Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hunan Dongting Pharmaceutical Main Business Overview
13.6.5 Hunan Dongting Pharmaceutical Latest Developments
13.7 Shanghai Zhaohui Pharmaceutical
13.7.1 Shanghai Zhaohui Pharmaceutical Company Information
13.7.2 Shanghai Zhaohui Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
13.7.3 Shanghai Zhaohui Pharmaceutical Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Zhaohui Pharmaceutical Main Business Overview
13.7.5 Shanghai Zhaohui Pharmaceutical Latest Developments
13.8 Endo International
13.8.1 Endo International Company Information
13.8.2 Endo International Perphenazine Drug Product Portfolios and Specifications
13.8.3 Endo International Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Endo International Main Business Overview
13.8.5 Endo International Latest Developments
13.9 Mitsubishi Tanabe
13.9.1 Mitsubishi Tanabe Company Information
13.9.2 Mitsubishi Tanabe Perphenazine Drug Product Portfolios and Specifications
13.9.3 Mitsubishi Tanabe Perphenazine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mitsubishi Tanabe Main Business Overview
13.9.5 Mitsubishi Tanabe Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Perphenazine Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Perphenazine Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Forms
Table 4. Major Players of Injectable Solution
Table 5. Global Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global Perphenazine Drug Sales Market Share by Type (2021-2026)
Table 7. Global Perphenazine Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global Perphenazine Drug Revenue Market Share by Type (2021-2026)
Table 9. Global Perphenazine Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Schizophrenia
Table 11. Major Players of Severe Nausea and Vomiting
Table 12. Major Players of Other
Table 13. Global Perphenazine Drug Sales by Psychiatric Indication (2021-2026) & (K Units)
Table 14. Global Perphenazine Drug Sales Market Share by Psychiatric Indication (2021-2026)
Table 15. Global Perphenazine Drug Revenue by Psychiatric Indication (2021-2026) & ($ million)
Table 16. Global Perphenazine Drug Revenue Market Share by Psychiatric Indication (2021-2026)
Table 17. Global Perphenazine Drug Sale Price by Psychiatric Indication (2021-2026) & (US$/Unit)
Table 18. Major Players of Psychiatric Hospital
Table 19. Major Players of General Hospital Psychiatry
Table 20. Major Players of Retail Pharmacy
Table 21. Global Perphenazine Drug Sales by Generic Supply Type (2021-2026) & (K Units)
Table 22. Global Perphenazine Drug Sales Market Share by Generic Supply Type (2021-2026)
Table 23. Global Perphenazine Drug Revenue by Generic Supply Type (2021-2026) & ($ million)
Table 24. Global Perphenazine Drug Revenue Market Share by Generic Supply Type (2021-2026)
Table 25. Global Perphenazine Drug Sale Price by Generic Supply Type (2021-2026) & (US$/Unit)
Table 26. Global Perphenazine Drug Sale by Application (2021-2026) & (K Units)
Table 27. Global Perphenazine Drug Sale Market Share by Application (2021-2026)
Table 28. Global Perphenazine Drug Revenue by Application (2021-2026) & ($ million)
Table 29. Global Perphenazine Drug Revenue Market Share by Application (2021-2026)
Table 30. Global Perphenazine Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Perphenazine Drug Sales by Company (2021-2026) & (K Units)
Table 32. Global Perphenazine Drug Sales Market Share by Company (2021-2026)
Table 33. Global Perphenazine Drug Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Perphenazine Drug Revenue Market Share by Company (2021-2026)
Table 35. Global Perphenazine Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Perphenazine Drug Producing Area Distribution and Sales Area
Table 37. Players Perphenazine Drug Products Offered
Table 38. Perphenazine Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Perphenazine Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Perphenazine Drug Sales Market Share Geographic Region (2021-2026)
Table 43. Global Perphenazine Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Perphenazine Drug Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Perphenazine Drug Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Perphenazine Drug Sales Market Share by Country/Region (2021-2026)
Table 47. Global Perphenazine Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Perphenazine Drug Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Perphenazine Drug Sales by Country (2021-2026) & (K Units)
Table 50. Americas Perphenazine Drug Sales Market Share by Country (2021-2026)
Table 51. Americas Perphenazine Drug Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 53. Americas Perphenazine Drug Sales by Application (2021-2026) & (K Units)
Table 54. APAC Perphenazine Drug Sales by Region (2021-2026) & (K Units)
Table 55. APAC Perphenazine Drug Sales Market Share by Region (2021-2026)
Table 56. APAC Perphenazine Drug Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 58. APAC Perphenazine Drug Sales by Application (2021-2026) & (K Units)
Table 59. Europe Perphenazine Drug Sales by Country (2021-2026) & (K Units)
Table 60. Europe Perphenazine Drug Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 62. Europe Perphenazine Drug Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Perphenazine Drug Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Perphenazine Drug Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Perphenazine Drug Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Perphenazine Drug
Table 68. Key Market Challenges & Risks of Perphenazine Drug
Table 69. Key Industry Trends of Perphenazine Drug
Table 70. Perphenazine Drug Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Perphenazine Drug Distributors List
Table 73. Perphenazine Drug Customer List
Table 74. Global Perphenazine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Perphenazine Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Perphenazine Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Perphenazine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Perphenazine Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Perphenazine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Perphenazine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Perphenazine Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Perphenazine Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Perphenazine Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Perphenazine Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Teva Pharmaceutical Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
Table 90. Teva Pharmaceutical Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Teva Pharmaceutical Main Business
Table 92. Teva Pharmaceutical Latest Developments
Table 93. Sandoz Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Sandoz Perphenazine Drug Product Portfolios and Specifications
Table 95. Sandoz Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Sandoz Main Business
Table 97. Sandoz Latest Developments
Table 98. Hikma Pharmaceuticals Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Hikma Pharmaceuticals Perphenazine Drug Product Portfolios and Specifications
Table 100. Hikma Pharmaceuticals Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hikma Pharmaceuticals Main Business
Table 102. Hikma Pharmaceuticals Latest Developments
Table 103. Amneal Pharmaceuticals Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Amneal Pharmaceuticals Perphenazine Drug Product Portfolios and Specifications
Table 105. Amneal Pharmaceuticals Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Amneal Pharmaceuticals Main Business
Table 107. Amneal Pharmaceuticals Latest Developments
Table 108. Shanghai Sine Pharmaceutical Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai Sine Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
Table 110. Shanghai Sine Pharmaceutical Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Shanghai Sine Pharmaceutical Main Business
Table 112. Shanghai Sine Pharmaceutical Latest Developments
Table 113. Hunan Dongting Pharmaceutical Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Hunan Dongting Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
Table 115. Hunan Dongting Pharmaceutical Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Hunan Dongting Pharmaceutical Main Business
Table 117. Hunan Dongting Pharmaceutical Latest Developments
Table 118. Shanghai Zhaohui Pharmaceutical Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai Zhaohui Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
Table 120. Shanghai Zhaohui Pharmaceutical Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Shanghai Zhaohui Pharmaceutical Main Business
Table 122. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 123. Endo International Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Endo International Perphenazine Drug Product Portfolios and Specifications
Table 125. Endo International Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Endo International Main Business
Table 127. Endo International Latest Developments
Table 128. Mitsubishi Tanabe Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Mitsubishi Tanabe Perphenazine Drug Product Portfolios and Specifications
Table 130. Mitsubishi Tanabe Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Mitsubishi Tanabe Main Business
Table 132. Mitsubishi Tanabe Latest Developments
Table 1. Perphenazine Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Perphenazine Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Forms
Table 4. Major Players of Injectable Solution
Table 5. Global Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global Perphenazine Drug Sales Market Share by Type (2021-2026)
Table 7. Global Perphenazine Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global Perphenazine Drug Revenue Market Share by Type (2021-2026)
Table 9. Global Perphenazine Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Schizophrenia
Table 11. Major Players of Severe Nausea and Vomiting
Table 12. Major Players of Other
Table 13. Global Perphenazine Drug Sales by Psychiatric Indication (2021-2026) & (K Units)
Table 14. Global Perphenazine Drug Sales Market Share by Psychiatric Indication (2021-2026)
Table 15. Global Perphenazine Drug Revenue by Psychiatric Indication (2021-2026) & ($ million)
Table 16. Global Perphenazine Drug Revenue Market Share by Psychiatric Indication (2021-2026)
Table 17. Global Perphenazine Drug Sale Price by Psychiatric Indication (2021-2026) & (US$/Unit)
Table 18. Major Players of Psychiatric Hospital
Table 19. Major Players of General Hospital Psychiatry
Table 20. Major Players of Retail Pharmacy
Table 21. Global Perphenazine Drug Sales by Generic Supply Type (2021-2026) & (K Units)
Table 22. Global Perphenazine Drug Sales Market Share by Generic Supply Type (2021-2026)
Table 23. Global Perphenazine Drug Revenue by Generic Supply Type (2021-2026) & ($ million)
Table 24. Global Perphenazine Drug Revenue Market Share by Generic Supply Type (2021-2026)
Table 25. Global Perphenazine Drug Sale Price by Generic Supply Type (2021-2026) & (US$/Unit)
Table 26. Global Perphenazine Drug Sale by Application (2021-2026) & (K Units)
Table 27. Global Perphenazine Drug Sale Market Share by Application (2021-2026)
Table 28. Global Perphenazine Drug Revenue by Application (2021-2026) & ($ million)
Table 29. Global Perphenazine Drug Revenue Market Share by Application (2021-2026)
Table 30. Global Perphenazine Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Perphenazine Drug Sales by Company (2021-2026) & (K Units)
Table 32. Global Perphenazine Drug Sales Market Share by Company (2021-2026)
Table 33. Global Perphenazine Drug Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Perphenazine Drug Revenue Market Share by Company (2021-2026)
Table 35. Global Perphenazine Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Perphenazine Drug Producing Area Distribution and Sales Area
Table 37. Players Perphenazine Drug Products Offered
Table 38. Perphenazine Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Perphenazine Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Perphenazine Drug Sales Market Share Geographic Region (2021-2026)
Table 43. Global Perphenazine Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Perphenazine Drug Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Perphenazine Drug Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Perphenazine Drug Sales Market Share by Country/Region (2021-2026)
Table 47. Global Perphenazine Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Perphenazine Drug Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Perphenazine Drug Sales by Country (2021-2026) & (K Units)
Table 50. Americas Perphenazine Drug Sales Market Share by Country (2021-2026)
Table 51. Americas Perphenazine Drug Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 53. Americas Perphenazine Drug Sales by Application (2021-2026) & (K Units)
Table 54. APAC Perphenazine Drug Sales by Region (2021-2026) & (K Units)
Table 55. APAC Perphenazine Drug Sales Market Share by Region (2021-2026)
Table 56. APAC Perphenazine Drug Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 58. APAC Perphenazine Drug Sales by Application (2021-2026) & (K Units)
Table 59. Europe Perphenazine Drug Sales by Country (2021-2026) & (K Units)
Table 60. Europe Perphenazine Drug Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 62. Europe Perphenazine Drug Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Perphenazine Drug Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Perphenazine Drug Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Perphenazine Drug Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Perphenazine Drug Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Perphenazine Drug
Table 68. Key Market Challenges & Risks of Perphenazine Drug
Table 69. Key Industry Trends of Perphenazine Drug
Table 70. Perphenazine Drug Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Perphenazine Drug Distributors List
Table 73. Perphenazine Drug Customer List
Table 74. Global Perphenazine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Perphenazine Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Perphenazine Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Perphenazine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Perphenazine Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Perphenazine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Perphenazine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Perphenazine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Perphenazine Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Perphenazine Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Perphenazine Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Perphenazine Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Teva Pharmaceutical Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
Table 90. Teva Pharmaceutical Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Teva Pharmaceutical Main Business
Table 92. Teva Pharmaceutical Latest Developments
Table 93. Sandoz Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Sandoz Perphenazine Drug Product Portfolios and Specifications
Table 95. Sandoz Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Sandoz Main Business
Table 97. Sandoz Latest Developments
Table 98. Hikma Pharmaceuticals Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Hikma Pharmaceuticals Perphenazine Drug Product Portfolios and Specifications
Table 100. Hikma Pharmaceuticals Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hikma Pharmaceuticals Main Business
Table 102. Hikma Pharmaceuticals Latest Developments
Table 103. Amneal Pharmaceuticals Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Amneal Pharmaceuticals Perphenazine Drug Product Portfolios and Specifications
Table 105. Amneal Pharmaceuticals Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Amneal Pharmaceuticals Main Business
Table 107. Amneal Pharmaceuticals Latest Developments
Table 108. Shanghai Sine Pharmaceutical Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai Sine Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
Table 110. Shanghai Sine Pharmaceutical Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Shanghai Sine Pharmaceutical Main Business
Table 112. Shanghai Sine Pharmaceutical Latest Developments
Table 113. Hunan Dongting Pharmaceutical Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Hunan Dongting Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
Table 115. Hunan Dongting Pharmaceutical Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Hunan Dongting Pharmaceutical Main Business
Table 117. Hunan Dongting Pharmaceutical Latest Developments
Table 118. Shanghai Zhaohui Pharmaceutical Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai Zhaohui Pharmaceutical Perphenazine Drug Product Portfolios and Specifications
Table 120. Shanghai Zhaohui Pharmaceutical Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Shanghai Zhaohui Pharmaceutical Main Business
Table 122. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 123. Endo International Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Endo International Perphenazine Drug Product Portfolios and Specifications
Table 125. Endo International Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Endo International Main Business
Table 127. Endo International Latest Developments
Table 128. Mitsubishi Tanabe Basic Information, Perphenazine Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Mitsubishi Tanabe Perphenazine Drug Product Portfolios and Specifications
Table 130. Mitsubishi Tanabe Perphenazine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Mitsubishi Tanabe Main Business
Table 132. Mitsubishi Tanabe Latest Developments
LIST OF FIGURES
Figure 1. Picture of Perphenazine Drug
Figure 2. Perphenazine Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Perphenazine Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Perphenazine Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Perphenazine Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Perphenazine Drug Sales Market Share by Country/Region (2025)
Figure 10. Perphenazine Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Forms
Figure 12. Product Picture of Injectable Solution
Figure 13. Global Perphenazine Drug Sales Market Share by Type in 2026
Figure 14. Global Perphenazine Drug Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Schizophrenia
Figure 16. Product Picture of Severe Nausea and Vomiting
Figure 17. Product Picture of Other
Figure 18. Global Perphenazine Drug Sales Market Share by Psychiatric Indication in 2026
Figure 19. Global Perphenazine Drug Revenue Market Share by Psychiatric Indication (2021-2026)
Figure 20. Product Picture of Psychiatric Hospital
Figure 21. Product Picture of General Hospital Psychiatry
Figure 22. Product Picture of Retail Pharmacy
Figure 23. Global Perphenazine Drug Sales Market Share by Generic Supply Type in 2026
Figure 24. Global Perphenazine Drug Revenue Market Share by Generic Supply Type (2021-2026)
Figure 25. Perphenazine Drug Consumed in Psychosis
Figure 26. Global Perphenazine Drug Market: Psychosis (2021-2026) & (K Units)
Figure 27. Perphenazine Drug Consumed in Antiemetic
Figure 28. Global Perphenazine Drug Market: Antiemetic (2021-2026) & (K Units)
Figure 29. Global Perphenazine Drug Sale Market Share by Application (2025)
Figure 30. Global Perphenazine Drug Revenue Market Share by Application in 2025
Figure 31. Perphenazine Drug Sales by Company in 2025 (K Units)
Figure 32. Global Perphenazine Drug Sales Market Share by Company in 2025
Figure 33. Perphenazine Drug Revenue by Company in 2025 ($ millions)
Figure 34. Global Perphenazine Drug Revenue Market Share by Company in 2025
Figure 35. Global Perphenazine Drug Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Perphenazine Drug Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Perphenazine Drug Sales 2021-2026 (K Units)
Figure 38. Americas Perphenazine Drug Revenue 2021-2026 ($ millions)
Figure 39. APAC Perphenazine Drug Sales 2021-2026 (K Units)
Figure 40. APAC Perphenazine Drug Revenue 2021-2026 ($ millions)
Figure 41. Europe Perphenazine Drug Sales 2021-2026 (K Units)
Figure 42. Europe Perphenazine Drug Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Perphenazine Drug Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Perphenazine Drug Revenue 2021-2026 ($ millions)
Figure 45. Americas Perphenazine Drug Sales Market Share by Country in 2025
Figure 46. Americas Perphenazine Drug Revenue Market Share by Country (2021-2026)
Figure 47. Americas Perphenazine Drug Sales Market Share by Type (2021-2026)
Figure 48. Americas Perphenazine Drug Sales Market Share by Application (2021-2026)
Figure 49. United States Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Perphenazine Drug Sales Market Share by Region in 2025
Figure 54. APAC Perphenazine Drug Revenue Market Share by Region (2021-2026)
Figure 55. APAC Perphenazine Drug Sales Market Share by Type (2021-2026)
Figure 56. APAC Perphenazine Drug Sales Market Share by Application (2021-2026)
Figure 57. China Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. India Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Perphenazine Drug Sales Market Share by Country in 2025
Figure 65. Europe Perphenazine Drug Revenue Market Share by Country (2021-2026)
Figure 66. Europe Perphenazine Drug Sales Market Share by Type (2021-2026)
Figure 67. Europe Perphenazine Drug Sales Market Share by Application (2021-2026)
Figure 68. Germany Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. France Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Perphenazine Drug Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Perphenazine Drug Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Perphenazine Drug Sales Market Share by Application (2021-2026)
Figure 76. Egypt Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Perphenazine Drug in 2026
Figure 82. Manufacturing Process Analysis of Perphenazine Drug
Figure 83. Industry Chain Structure of Perphenazine Drug
Figure 84. Channels of Distribution
Figure 85. Global Perphenazine Drug Sales Market Forecast by Region (2027-2032)
Figure 86. Global Perphenazine Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Perphenazine Drug Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Perphenazine Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Perphenazine Drug Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Perphenazine Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Perphenazine Drug
Figure 2. Perphenazine Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Perphenazine Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Perphenazine Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Perphenazine Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Perphenazine Drug Sales Market Share by Country/Region (2025)
Figure 10. Perphenazine Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Forms
Figure 12. Product Picture of Injectable Solution
Figure 13. Global Perphenazine Drug Sales Market Share by Type in 2026
Figure 14. Global Perphenazine Drug Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Schizophrenia
Figure 16. Product Picture of Severe Nausea and Vomiting
Figure 17. Product Picture of Other
Figure 18. Global Perphenazine Drug Sales Market Share by Psychiatric Indication in 2026
Figure 19. Global Perphenazine Drug Revenue Market Share by Psychiatric Indication (2021-2026)
Figure 20. Product Picture of Psychiatric Hospital
Figure 21. Product Picture of General Hospital Psychiatry
Figure 22. Product Picture of Retail Pharmacy
Figure 23. Global Perphenazine Drug Sales Market Share by Generic Supply Type in 2026
Figure 24. Global Perphenazine Drug Revenue Market Share by Generic Supply Type (2021-2026)
Figure 25. Perphenazine Drug Consumed in Psychosis
Figure 26. Global Perphenazine Drug Market: Psychosis (2021-2026) & (K Units)
Figure 27. Perphenazine Drug Consumed in Antiemetic
Figure 28. Global Perphenazine Drug Market: Antiemetic (2021-2026) & (K Units)
Figure 29. Global Perphenazine Drug Sale Market Share by Application (2025)
Figure 30. Global Perphenazine Drug Revenue Market Share by Application in 2025
Figure 31. Perphenazine Drug Sales by Company in 2025 (K Units)
Figure 32. Global Perphenazine Drug Sales Market Share by Company in 2025
Figure 33. Perphenazine Drug Revenue by Company in 2025 ($ millions)
Figure 34. Global Perphenazine Drug Revenue Market Share by Company in 2025
Figure 35. Global Perphenazine Drug Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Perphenazine Drug Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Perphenazine Drug Sales 2021-2026 (K Units)
Figure 38. Americas Perphenazine Drug Revenue 2021-2026 ($ millions)
Figure 39. APAC Perphenazine Drug Sales 2021-2026 (K Units)
Figure 40. APAC Perphenazine Drug Revenue 2021-2026 ($ millions)
Figure 41. Europe Perphenazine Drug Sales 2021-2026 (K Units)
Figure 42. Europe Perphenazine Drug Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Perphenazine Drug Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Perphenazine Drug Revenue 2021-2026 ($ millions)
Figure 45. Americas Perphenazine Drug Sales Market Share by Country in 2025
Figure 46. Americas Perphenazine Drug Revenue Market Share by Country (2021-2026)
Figure 47. Americas Perphenazine Drug Sales Market Share by Type (2021-2026)
Figure 48. Americas Perphenazine Drug Sales Market Share by Application (2021-2026)
Figure 49. United States Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Perphenazine Drug Sales Market Share by Region in 2025
Figure 54. APAC Perphenazine Drug Revenue Market Share by Region (2021-2026)
Figure 55. APAC Perphenazine Drug Sales Market Share by Type (2021-2026)
Figure 56. APAC Perphenazine Drug Sales Market Share by Application (2021-2026)
Figure 57. China Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. India Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Perphenazine Drug Sales Market Share by Country in 2025
Figure 65. Europe Perphenazine Drug Revenue Market Share by Country (2021-2026)
Figure 66. Europe Perphenazine Drug Sales Market Share by Type (2021-2026)
Figure 67. Europe Perphenazine Drug Sales Market Share by Application (2021-2026)
Figure 68. Germany Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. France Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Perphenazine Drug Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Perphenazine Drug Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Perphenazine Drug Sales Market Share by Application (2021-2026)
Figure 76. Egypt Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Perphenazine Drug Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Perphenazine Drug in 2026
Figure 82. Manufacturing Process Analysis of Perphenazine Drug
Figure 83. Industry Chain Structure of Perphenazine Drug
Figure 84. Channels of Distribution
Figure 85. Global Perphenazine Drug Sales Market Forecast by Region (2027-2032)
Figure 86. Global Perphenazine Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Perphenazine Drug Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Perphenazine Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Perphenazine Drug Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Perphenazine Drug Revenue Market Share Forecast by Application (2027-2032)
